Recognizing dapagliflozin overdose in ICU patients admitted for metformin poisoning.
Official title: Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning
Run by Centre Hospitalier de Saint-Denis · NCT07193069 · Data updated 2026-11-12
This project will see if clinical signs and routine lab tests can help doctors tell whether adults in the ICU for metformin poisoning also took too much dapagliflozin.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Centre Hospitalier de Saint-Denis Academic / other |
| Locations | 1 site (Saint-Denis, France) |
| Status | Recruiting |
| Started | April 11, 2025 |
| Main results expected | April 11, 2026 |
| Study ends | April 11, 2026 |
| Registry record updated | September 25, 2025 |
| Trial ID | NCT07193069 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older admitted to the ICU for acute drug poisoning with documented exposure to metformin alone or to metformin plus dapagliflozin are eligible.
✕Probably not a fit
People who were not exposed to metformin, who took dapagliflozin without metformin, or who are treated outside the ICU are unlikely to benefit from this study's findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational comparison of adults admitted to a single ICU for acute metformin poisoning, separating patients exposed to metformin alone from those exposed to both metformin and dapagliflozin. Researchers will review clinical data and standard laboratory results—such as acid-base status, lactate, ketones, glucose, and need for dialysis or vasopressors—collected during ICU care. The team will look for patterns or distinct findings that appear more often when dapagliflozin is involved. Results aim to identify timely clues clinicians can use at the bedside to suspect combined overdose and guide management decisions.
Why it matters
Potential benefit: If successful, the findings could help clinicians recognize dapagliflozin involvement earlier and tailor treatment to reduce complications and improve outcomes.
How similar studies have gone: There is limited published data specifically on combined metformin and dapagliflozin overdoses, so this is a relatively novel, underreported clinical question.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older * Admission to an intensive care unit (ICU) due to acute drug poisoning * Documented exposure to either: * Metformin alone * Metformin in combination with dapagliflozin Exclusion Criteria: * Patients under 18 years of age * No exposure to metformin * Exposure to dapagliflozin without metformin
Where it's running
-
Centre Hospitalier de Saint-Denis
Saint-Denis, France, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Perfusion index in the emergency department to gauge DKA severity
This study tests whether the perfusion index measured at ED admission can help predict how severe diabetic ketoacidosis will be in adults.
-
The ENHANCE Project Toolkit
This pilot study tests a bundle of smartphone and online tools to help people who use drugs reduce overdose risk.
-
Ventilation During Transport of Mechanically Ventilated Patients After Non-Cardiac Surgery
This observational study looks at how patients who stay intubated after non-cardiac surgery are ventilated during the move from the operating room to the ICU.
-
Preventive Narrative Exposure for PTSD After Cardiac Surgery in the ICU
In adults having cardiopulmonary bypass heart surgery, this trial tests whether an ICU-based narrative exposure intervention helps prevent posttraumatic stress symptoms compared with standard care.
-
Predicting who will need ICU care after cancer surgery
This study will test common risk scores to see if they can predict which adult cancer surgery patients will need ICU care after their operation.
-
Markers of early kidney and heart injury in children newly diagnosed with type 1 diabetes
This study will test whether blood markers and heart ultrasound can find early kidney or heart injury in children aged 2–16 who are newly diagnosed with type 1 diabetes, comparing those with diabetic ketoacidosis, those without, and healthy children.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.